A large meta-analysis identifies patient, clinical, and biochemical factors linked to early mortality in septic shock, helping clinicians stratify risk.
Johns Hopkins University researchers have shown that hospitals can more accurately classify sepsis patients into four distinct categories that prioritize early interventions for those at the highest ...
Please provide your email address to receive an email when new articles are posted on . “Even though septic shock is a well-recognized deadly condition, our study, one of the first to use the Sepsis-3 ...
ORLANDO -- Only about a quarter of intensive care unit (ICU) patients with septic shock were given corticosteroids, and this varied widely by physician and ICU, according to a retrospective cohort ...
The following article features coverage from CHEST 2021, being held virtually from October 17 to October 20, 2021. Click here to read more of MPR‘s conference coverage. Hospital fluid culture is ...
Please provide your email address to receive an email when new articles are posted on . The findings indicated the need for an urgent call to action and increased awareness of septic shock in this ...
PARIS--(BUSINESS WIRE)--Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory syndromes, disclosed for the first time today at the ...
(Boston)—Sepsis occurs in approximately 1.7 million hospitalizations in the U.S. with in more than a third of hospitalizations resulting in death. Patients with septic shock benefit from steroid ...
In a remarkable display of swift clinical judgement and multidisciplinary coordination, doctors at Fortis Hospital, Greater Noida, successfully treated a critically ill 9-year-old boy suffering from a ...
Adrenomed AG is translating the concept of precision medicine to acute care with a biomarker-guided antibody therapy for sepsis and septic shock. With a mortality rate of 20–30% in developed countries ...
KANSAS CITY, Mo.--(BUSINESS WIRE)--Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic shock and hemorrhagic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results